Dacarbazine and disease progression Patient Reports February 11, 2012

Dacarbazine Side Effects Report #5513260-0
Dacarbazine side effect was reported by a Health Professional from UNITED STATES on Oct 22, 2007. Male patient, 72 years of age, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: disease progression. Dacarbazine dosage: 2020MG. Patient died on 02/26/2007.

Dacarbazine Side Effects Report #4920770-3
Dacarbazine side effect was reported by a Physician from UNITED STATES on Jan 25, 2006. Male patient, 70 years of age, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: disease progression, metastatic malignant melanoma. Dacarbazine dosage: 2270-2250 MG INTRAVENOUS; 2270 MG INTRAVENOUS; 2270 MG INTRAVENOUS; 2250 INTRAVENOUS. Patient was hospitalized. Patient died on 01/19/2006.

Dacarbazine Side Effects Report #5712364-7
Dacarbazine side effect was reported by a Physician from UNITED STATES on Mar 26, 2008. Male patient, 68 years of age, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: disease progression. Dacarbazine dosage: 1710 MG;. Patient died on 03/06/2008.

Dacarbazine Side Effects Report #4909182-6
Dacarbazine side effect was reported by a Pharmacist from UNITED STATES on Jan 27, 2006. Female patient, 67 years of age, weighting 119.0 lb, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: disease progression. Dacarbazine dosage: unknown. Patient died on 09/22/2005.


Dacarbazine Side Effects Report #5482013-4
Dacarbazine side effect was reported by a Health Professional from UNITED STATES on Sept 24, 2007. Male patient, 66 years of age, weighting 169.8 lb, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: disease progression, neutropenia, overdose. Dacarbazine dosage: 1940 MG. Patient recovered.

Dacarbazine Side Effects Report #4909178-4
Dacarbazine side effect was reported by a Health Professional from UNITED STATES on Jan 27, 2006. Male patient, 60 years of age, weighting 156.5 lb, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: disease progression, fall , haemorrhage, head injury. Dacarbazine dosage: 1880MG/IV. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #4934212-5
Dacarbazine side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 17, 2006. Male patient, 60 years of age, weighting 156.5 lb, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: disease progression, fall , haemorrhage, head injury, malignant neoplasm progression, metastatic malignant melanoma, pleural effusion. Dacarbazine dosage: 1880MG/IV. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #4886540-X
Dacarbazine side effect was reported by a Physician from UNITED STATES on Dec 21, 2005. Female patient, 58 years of age, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: disease progression. Dacarbazine dosage: 1170 MG INTRAVENOUS. Patient died on 11/09/2005.

Dacarbazine Side Effects Report #4886564-2
Dacarbazine side effect was reported by a Physician from UNITED STATES on Jan 10, 2006. Female patient, 58 years of age, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: disease progression. Dacarbazine dosage: 1170 MG/IV. Patient died on 11/09/2005.


Dacarbazine Side Effects Report #4870959-7
Dacarbazine side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 11, 2005. Female patient, 46 years of age, weighting 169.8 lb, was diagnosed with metastatic malignant melanoma, computerised tomogram and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: anaphylactic reaction, blood pressure immeasurable, dehydration, disease progression, infusion related reaction, loss of consciousness, lymphocyte count decreased, nausea , nervous system disorder. Dacarbazine dosage: unknown. During the same period patient was treated with CONTRAST DYEECTABLE, OXYCODONE, OXYCONTIN, COMPAZINE. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #4917224-7
Dacarbazine side effect was reported by a Physician from UNITED STATES on Feb 01, 2006. Male patient, 45 years of age, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: disease progression, malignant neoplasm progression, metastatic malignant melanoma, nervous system disorder. Dacarbazine dosage: 2100MG/IV. Patient died on 12/20/2005.

Dacarbazine Side Effects Report #4870962-7
Dacarbazine side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 22, 2005. Female patient, 44 years of age, weighting 169.8 lb, was diagnosed with metastatic malignant melanoma, scan and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: anaphylactic reaction, dehydration, disease progression, loss of consciousness, lymphocyte count decreased, nausea , nervous system disorder, resuscitation, sepsis . Dacarbazine dosage: unknown. During the same period patient was treated with CONTRAST DYEECTABLE, OXYCODONE, OXYCONTIN, COMPAZINE. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5030416-4
Dacarbazine side effect was reported by a Health Professional from UNITED STATES on June 12, 2006. Female patient, 36 years of age, weighting 335.1 lb, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: diarrhoea, disease progression, malaise, metastases to stomach, pancreatitis. Dacarbazine dosage: 2510-2530 MG/IV. Patient was hospitalized. Patient died on 04/25/2006.

Dacarbazine Side Effects Report #5030418-8
Dacarbazine side effect was reported by a Health Professional from UNITED STATES on Feb 13, 2006. Female patient, 36 years of age, weighting 335.1 lb, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: diarrhoea, disease progression, malaise, metastases to lung, metastases to stomach, metastases to the mediastinum, metastatic malignant melanoma, pancreatic mass, pancreatitis. Dacarbazine dosage: unknown. During the same period patient was treated with LEXAPRO, PROTONIX, LISINOPRIL. Patient was hospitalized. Patient died on 04/25/2006.


Dacarbazine Side Effects Report #4667668-6
Dacarbazine side effect was reported by a Health Professional from on May 19, 2005. Female patient, 44 years of age, weighting 123.0 lb, was diagnosed with malignant melanoma stage iv and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: disease progression, hyponatraemia. Dacarbazine dosage: 250 MG/M2 Q WEEK IV. During the same period patient was treated with BORTAZOMIB, OXYCONTIN, LORAZEPAM, PTASSIUM, ADVIL ALERGY SINUS. Patient was hospitalized. Patient died on 05/06/2005.

Dacarbazine Side Effects Report #4669062-0
Dacarbazine side effect was reported by a Physician from on May 05, 2005. Male patient, 65 years of age, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: blood urea increased, brain oedema, cerebral haematoma, cerebral haemorrhage, disease progression, fall , head injury, hyperglycaemia, metastases to central nervous system. Dacarbazine dosage: 2340 MG (2340 MG, 1 IN 1 D), INTRAVENOUS. During the same period patient was treated with GENASENSE, METFORMIN, ASPIRIN, ATENOLOL, QUINAPRIL, ATORVASTATIN CALCIUM, TELMISARTAN, GLIPIZIDE. Patient was hospitalized and became disabled. Patient recovered.

Dacarbazine Side Effects Report #5513197-7
Dacarbazine side effect was reported by a Health Professional from UNITED STATES on Oct 22, 2007. Female patient, 42 years of age, weighting 138.9 lb, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: back pain , disease progression, pneumonia , pulmonary embolism . Dacarbazine dosage: 1700MG/EVERY 22 DAYS/IV. During the same period patient was treated with REFER TO MEDWATCH #. Patient was hospitalized. Patient died on 06/18/2007.

Dacarbazine Side Effects Report #5525358-1
Dacarbazine side effect was reported by a Health Professional from SWEDEN on Nov 06, 2007. Female patient, 42 years of age, weighting 138.9 lb, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: back pain , disease progression, pneumonia , pulmonary embolism . Dacarbazine dosage: 1700MG/EVERY 22 DAYS/IV. Patient was hospitalized. Patient died on 06/18/2007.

Dacarbazine Side Effects Report #5525732-3
Dacarbazine side effect was reported by a Physician from SWEDEN on Oct 19, 2007. Female patient, 42 years of age, weighting 138.9 lb, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: disease progression, pneumonia , pulmonary embolism . Dacarbazine dosage: 1700 MG (1700 MG, DAILY- EVERY 22 DAYS), INTRAVENOUS. During the same period patient was treated with BISOPROLOL FUMARATE, ALLOPURINOL, IMOVANE. Patient was hospitalized. Patient recovered.


Dacarbazine Side Effects Report #5701335-2
Dacarbazine side effect was reported by a Physician from SWEDEN on Mar 10, 2008. Female patient, 42 years of age, weighting 138.9 lb, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: disease progression, pneumonia , pulmonary embolism . Dacarbazine dosage: 1700 MG (1700 MG, DAILY- EVERY 22 DAYS), INTRAVENOUS. During the same period patient was treated with BISOPROLOL, ALLOPURINOL, IMOVANE. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #6121921-8
Dacarbazine side effect was reported by a Health Professional from UNITED STATES on Mar 02, 2009. Female patient, 42 years of age, weighting 138.9 lb, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: back pain , disease progression, pneumonia , pulmonary embolism . Dacarbazine dosage: 1700MG/EVERY 22 DAYS/IV. Patient was hospitalized. Patient died on 06/18/2007.

Dacarbazine Side Effects Report #4664847-9
Dacarbazine side effect was reported by a Health Professional from on May 17, 2005. Female patient, 39 years of age, weighting 116.0 lb, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: abdominal pain , constipation , disease progression. Dacarbazine dosage: 1600 MG IV. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #4682479-3
Dacarbazine side effect was reported by a Health Professional from on June 02, 2005. Female patient, 39 years of age, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: constipation , disease progression. Dacarbazine dosage: 1600 MG IV. Patient died on 05/24/2005.

Dacarbazine Side Effects Report #5661935-5
Dacarbazine side effect was reported by a Physician from UNITED STATES on Mar 10, 2008. Male patient, weighting 179.9 lb, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: disease progression, gastrointestinal haemorrhage, mass. Dacarbazine dosage: 1600MG, IV Q21DAYS. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.


Dacarbazine Side Effects Report #5763750-0
Dacarbazine side effect was reported by a Physician from UNITED STATES on June 06, 2008. Male patient, weighting 158.5 lb, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: cellulitis , disease progression. Dacarbazine dosage: 1870MG, IV 21DAYS. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5857633-5
Dacarbazine side effect was reported by a Physician from UNITED STATES on Aug 25, 2008. Female patient, weighting 169.1 lb, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: anaemia, disease progression. Dacarbazine dosage: 200MG, IV Q21DAYS. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5939954-0
Dacarbazine side effect was reported by a Physician from UNITED STATES on Oct 31, 2008. Female patient, weighting 180.8 lb, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: anaemia, disease progression, neutrophil count abnormal, thrombocytopenia. Dacarbazine dosage: 1500MG IV Q21DAYS. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5963431-4
Dacarbazine side effect was reported by a Physician from UNITED STATES on Nov 21, 2008. Female patient, weighting 183.2 lb, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: disease progression, skin candida. Dacarbazine dosage: 1910MG, IV Q21 DAYS. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #6003234-8
Dacarbazine side effect was reported by a Physician from UNITED STATES on Dec 15, 2008. Female patient, weighting 183.2 lb, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: disease progression. Dacarbazine dosage: 1910MG, IV Q21DAYS. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.


Dacarbazine Side Effects Report #6059381-8
Dacarbazine side effect was reported by a Health Professional from UNITED STATES on Jan 28, 2009. Male patient, weighting 187.6 lb, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, dehydration, disease progression, heart rate increased, myeloproliferative disorder, pneumonia primary atypical, pulmonary congestion. Dacarbazine dosage: 800MG/M2 Q3 WEEKS. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient died on 01/20/2009.

Dacarbazine Side Effects Report #6077039-6
Dacarbazine side effect was reported by a Physician from UNITED STATES on Feb 11, 2009. Male patient, weighting 196.7 lb, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, nuclear magnetic resonance imaging brain abnormal. Dacarbazine dosage: 1050MG, Q21DAYS, IV. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient died on 02/04/2009.

Dacarbazine Side Effects Report #6005900-7
Dacarbazine side effect was reported by a Physician from UNITED STATES on Dec 16, 2008. Male patient, weighting 179.5 lb, was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: abdominal pain , disease progression, fatigue. Dacarbazine dosage: 1970MG, IV, Q21DAYS. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.